Sepsis Limited
Rapid Diagnosis of Bacterial Sepsis in Acute Settings
- Funding £95,500
- Competition Acute Care - Hospital Resource Usage
- Competition Date Spring 2016
- Local AHSN Greater Manchester AHSN
- Website
- Key Contact
- Status Please Select
Based on a clinically validated biological assay this project will test a prototype point of care device for use in close proximity of a patient. The assay detects abnormal blood chemistry due to bacterial sepsis, within minutes of sampling and before standard physiological sepsis is diagnosed and has been shown in children and adults in settings that include post-surgery, oncology, acute medical and intensive care units. It has been designed to frequently monitor progression of symptoms with a view to improve overall antibiotic stewardship to collectively meet objectives of the Department of Health “UK Five Year Antimicrobial Resistance Strategy 2013-2018.
Comments are closed.